In its final days, the Biden administration's FDA is expected to propose a limit on the amount of nicotine in cigarettes.

Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...

The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.

It’s taken nearly a decade for the U.S. FDA to go from zero to 60 in approving biosimilars. Currently, 63 biosimilars have been approved in the U.S., thanks to 18 new approvals in 2024 that stretched ...

The FDA recommended patients obtain drugs with "a prescription from their doctor and fill the prescription at a state-licensed pharmacy." Patrizia Cavazzoni, the director of the FDA’s Center for ...

supply will also meet or exceed projected demand," Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, wrote in a letter published on the agency's website.

It’s the second time in less than a month that retailer has recalled the medication; this time due to a potential foreign ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...